Issue of Equity
Summary by AI BETAClose X
Pembroke VCT plc (the "Company")
Issue of B Ordinary Shares of 1p each ("B Ordinary Shares") pursuant to an Offer for Subscription for up to £40 million of B Ordinary Shares with an over-allotment facility for up to a further £20 million of B Ordinary Shares (the "Offer")
On 5 March 2026, 3,139,962 B Ordinary Shares (the "Shares") were allotted pursuant to the Offer. In accordance with the terms and conditions of the Offer, the offer prices at which the Shares were allotted were calculated by reference to the unaudited net asset value of a B Ordinary Share in the Company as at 31 December 2025 of 100.2p per B Ordinary Share. The offer prices at which the Shares were issued and allotted ranged from 96.70p to 103.81p per B Ordinary Share.
Following the allotment above, the total number of B Ordinary Shares in issue is 283,941,899. Therefore, the total number of voting rights in the Company is 283,941,899. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Application for the Shares to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities will be made shortly and dealings are expected to commence on or around 12 March 2026. CREST accounts are expected to be credited as soon as practicable following the allotment and definitive documents of title are expected to be dispatched within ten business days of allotment.
Following this allotment, the total number of shares issued pursuant to the Offer is 24,370,785 B Ordinary Shares.
For further information, please contact:
Andrew Wolfson / Chris Lewis
Pembroke Investment Managers LLP (Manager)
+44 20 7766 6900
Ben Harber FCG (Company Secretary)
Keith Lassman
Howard Kennedy Corporate Services LLP
keith.lassman@howardkennedy.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 19 minutes ago GSK
- 20 minutes ago 3i Group
- 1 hour ago M&G
- 1 hour ago AJ Bell
- 1 hour ago Pembroke Vct B